Stay informed about important trends and policies that impact your commercialisation strategies.
To develop and execute successful real world evidence, commercialisation and market access strategies for your product pipeline and on-market products, you need to stay fully informed about ongoing developments in global healthcare systems, relevant pricing and reimbursement trends and policies.
Our Commercialisation & Outcomes Briefings provide insights, information, and analysis on:
- Payer trends, and drivers of market access success
- Pricing policy and regulations in key markets
- Regulatory agency requirements and policies that govern market approval, and the impact on reimbursement decisions
- Innovative therapeutic advancements
ACR 2018 Annual Meeting Briefing
Read the complete briefing for details and perspective from the recent American College of Rheumatology meeting.
Current Issue – November 2018
ICON Access, Commercialisation & Communications experts recently attended the 2018 ACR Annual Meeting in Chicago, IL October 19-24.
The meeting proceedings covered advances in drug development and clinical care approaches, with a focus on delivering optimal patient outcomes and increasing access to safe, effective therapies in rheumatology care. Presentation topics focused on biosimilars, JAK inhibitors, long-term experience with recently-approved therapies, and increasingly accurate predictive, diagnostic, and monitoring tools. The conference also addressed the growing role of patient-level data and patient perspectives in drug development efforts and regulatory decisions.
Download our complete briefing for additional details and perspective on the most notable and impactful presentations and activities at the conference.